These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 2029074)

  • 1. Successful treatment of severe aplastic anemia by bone marrow transplantation from HLA nonidentical family members: preliminary results utilizing cyclophosphamide and 600 cGY fractionated total body irradiation.
    Gordon BG; Strandjord SE; Warkentin PI; Kadushin J; Coccia PF
    Am J Pediatr Hematol Oncol; 1991; 13(1):29-33. PubMed ID: 2029074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Marrow transplants from unrelated donors for patients with aplastic anemia: minimum effective dose of total body irradiation.
    Deeg HJ; Amylon ID; Harris RE; Collins R; Beatty PG; Feig S; Ramsay N; Territo M; Khan SP; Pamphilon D; Leis JF; Burdach S; Anasetti C; Hackman R; Storer B; Mueller B
    Biol Blood Marrow Transplant; 2001; 7(4):208-15. PubMed ID: 11349807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperfractionated total lymphoid irradiation and cyclophosphamide for preparation of previously transfused patients undergoing HLA-identical marrow transplantation for severe aplastic anemia.
    Castro-Malaspina H; Childs B; Laver J; Shank B; Brochstein J; Gillio A; Flomenberg N; Young J; Boulad F; Black P
    Int J Radiat Oncol Biol Phys; 1994 Jul; 29(4):847-54. PubMed ID: 8040033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
    Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J
    Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Marrow transplant experience for children with severe aplastic anemia.
    Sanders JE; Storb R; Anasetti C; Deeg HJ; Doney K; Sullivan KM; Witherspoon RP; Hansen J
    Am J Pediatr Hematol Oncol; 1994 Feb; 16(1):43-9. PubMed ID: 8311172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone marrow transplantation for severe aplastic anemia from genotypically HLA-nonidentical relatives. An update of the Seattle experience.
    Wagner JL; Deeg HJ; Seidel K; Anasetti C; Doney K; Sanders J; Sullivan KM; Storb R
    Transplantation; 1996 Jan; 61(1):54-61. PubMed ID: 8560574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful bone marrow transplantation in children with severe aplastic anemia using HLA-partially matched family donors.
    Locatelli F; Porta F; Zecca M; Pedrazzoli P; Maccario R; Giani S; Vitale V; Martinetti M; Mazzolari E; Lanfranchi A
    Am J Hematol; 1993 Mar; 42(3):328-33. PubMed ID: 8438907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unrelated donor bone marrow transplants for severe aplastic anemia with conditioning using total body irradiation and cyclophosphamide.
    Kim SY; Lee JW; Lim J; Cho BS; Eom KS; Kim YJ; Kim HJ; Lee S; Min CK; Cho SG; Kim DW; Min WS; Kim CC
    Biol Blood Marrow Transplant; 2007 Jul; 13(7):863-70. PubMed ID: 17580265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CY/TBI-800 as a pretransplant regimen for allogeneic bone marrow transplantation for severe aplastic anemia using HLA-haploidentical family donors.
    Tzeng CH; Chen PM; Fan S; Liu JH; Chiou TJ; Hsieh RK
    Bone Marrow Transplant; 1996 Aug; 18(2):273-7. PubMed ID: 8864434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unrelated donor bone marrow transplants in children.
    Grovas A; Feig SA; O'Rourke S; Valentino L; Wiley F; Hunt L; Landaw EM; Gajewski J
    Cell Transplant; 1994; 3(5):413-20. PubMed ID: 7827779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-total body irradiation containing preparative regimen in alternative donor bone marrow transplantation for severe aplastic anemia.
    Lee JH; Choi SJ; Lee JH; Lee YS; Seol M; Ryu SG; Lee JS; Kim WK; Lee KH
    Bone Marrow Transplant; 2005 Apr; 35(8):755-61. PubMed ID: 15735661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beneficial Role of Low-Dose Antithymocyte Globulin in Unrelated Stem Cell Transplantation for Adult Patients with Acquired Severe Aplastic Anemia: Reduction of Graft-versus-Host Disease and Improvement of Graft-versus-Host Disease-Free, Failure-Free Survival Rate.
    Park SS; Kwak DH; Jeon YW; Yoon JH; Lee SE; Cho BS; Eom KS; Kim YJ; Kim HJ; Lee S; Min CK; Cho SG; Kim DW; Min WS; Lee JW
    Biol Blood Marrow Transplant; 2017 Sep; 23(9):1498-1508. PubMed ID: 28554856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Marrow transplantation in hepatitis-associated aplastic anemia.
    Witherspoon RP; Storb R; Shulman H; Buckner CD; Deeg HJ; Clift RA; Sanders JE; Doney K; McDonald G; Sullivan KM
    Am J Hematol; 1984 Oct; 17(3):269-78. PubMed ID: 6383025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Favorable effect on acute and chronic graft-versus-host disease with cyclophosphamide and in vivo anti-CD52 monoclonal antibodies for marrow transplantation from HLA-identical sibling donors for acquired aplastic anemia.
    Gupta V; Ball SE; Yi QL; Sage D; McCann SR; Lawler M; Ortin M; Freires M; Hale G; Waldmann H; Gordon-Smith EC; Marsh JC
    Biol Blood Marrow Transplant; 2004 Dec; 10(12):867-76. PubMed ID: 15570255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Allogeneic bone marrow transplantation after fractionated whole body irradiation. Results at the Kiel transplantation center].
    Schmitz N; Kayser W; Gassmann W; Euler HH; Wüstemann M; Brix F; Dühmke E; Hebbinghaus D; Gremmel H; Schaub J
    Dtsch Med Wochenschr; 1985 Sep; 110(39):1488-93. PubMed ID: 3896727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term outcome after bone marrow transplantation for aplastic anemia using cyclophosphamide and total lymphoid irradiation as conditioning regimen.
    Inamoto Y; Suzuki R; Kuwatsuka Y; Yasuda T; Takahashi T; Tsujimura A; Sugimoto K; Oba T; Terakura S; Atsuta Y; Murata M; Ito M; Kodera Y; Miyamura K
    Biol Blood Marrow Transplant; 2008 Jan; 14(1):43-9. PubMed ID: 18158960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of mixed chimerism on graft-versus-host disease, disease recurrence and survival after HLA-identical marrow transplantation for aplastic anemia or chronic myelogenous leukemia.
    Huss R; Deeg HJ; Gooley T; Bryant E; Leisenring W; Clift R; Buckner CD; Martin P; Storb R; Appelbaum FR
    Bone Marrow Transplant; 1996 Oct; 18(4):767-76. PubMed ID: 8899193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Donors other than HLA-identical siblings.
    Buckner CD; Sanders JE; Anasetti C; Beatty P; Hansen JA; Storb R; Clift R; Thomas ED
    Prog Clin Biol Res; 1989; 309():383-90. PubMed ID: 2675107
    [No Abstract]   [Full Text] [Related]  

  • 19. Feasibility and results of bone marrow transplantation from an HLA-mismatched unrelated donor for children and young adults with acquired severe aplastic anemia.
    Yagasaki H; Takahashi Y; Kudo K; Ohashi H; Hama A; Yamamoto T; Tanaka M; Yoshida N; Hidaka H; Nishio N; Kojima S
    Int J Hematol; 2007 Jun; 85(5):437-42. PubMed ID: 17562622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone marrow transplantation for severe aplastic anemia in children.
    Casper JT; Truitt RR; Baxter-Lowe LA; Ash RC
    Am J Pediatr Hematol Oncol; 1990; 12(4):434-48. PubMed ID: 2285124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.